BioAnalytical Instruments Reagents and Supplies
Closed Solicitation Posted
- Solicitation number
- 75D301-25-Q-78604
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- Place of performance
- San Juan, Puerto Rico 00920, United States
- Points of contact
-
- Sandra Adams ab41@cdc.gov (770) 488-5543
- Sheena Delaine kpz5@cdc.gov (770) 488-2974
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), specifically the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), is seeking to procure specific FDA-approved diagnostic enzymes and laboratory reagents for disease surveillance programs. The solicitation (number 75D301-25-Q-78604) focuses on critical reagents including SuperScript III Platinum CDC Triplex RT-PCR, SuperScript III Platinum CDC DENV-1-4 RT-PCR, TaPath CDC COVID-19 RT-PCR, and TaPath CDC Influenza RT PCR. The procurement will be conducted using Simplified Acquisitions Procedures, with quotes evaluated on a lowest price technically acceptable basis. Vendors must submit pricing for specific line items by May 13, 2025, at 4:00 pm, with the evaluation focusing on compliance with FDA test specifications and technical requirements. Potential bidders must be able to provide these specialized laboratory supplies that meet strict quality assurance and reproducibility standards.
The solicitation is not set aside for any specific business type, though it falls under the Medical Laboratories NAICS category (621511) with a small business size standard of $41.5 million. BioAnalytical Instruments is identified as the sole authorized local distributor of Gibco, Invitrogen, and Thermo Fisher Scientific products in Puerto Rico. The contract will have a 3-month performance period from June 2, 2025, to September 12, 2025, with multiple delivery dates for various quantities of reagents. The place of performance is located at 498 Calle Baleares, San Juan, Puerto Rico 00920, specifically at the CDC NCID San Juan Laboratories. While the exact award value is not explicitly stated, the procurement is under the $250,000 threshold and is justified as a sole source procurement under FAR 13.106-1(b)(1) due to specific brand and technical requirements.
Notice text
This procurement is for the purchase of approved FDA reagents. FDA approved tests performed at the laboratory requre the use of the specific enzymes listed below:
SuperScript TM III Platinum TM CDC Triplex RT-PCR IDV EUA
SuperScript TM III Platinum TM CDC DENV-1-4 RT-PCR IDV 510K
TaPath TM CDC COVID-19 RT-PCR IDV 510K
TaPath TM CDC Influenza RT PCR IDV 510K
Attachments
| File | Type | Posted |
|---|---|---|
| SSJ_Redacted MLG.pdf SL signed 9 May 25.pdf | ||
| Combined Synopsis-Solicitation--.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity